CPX-351 Plus Enasidenib for Relapsed AML

Conditions

• Recurrent Acute Myeloid Leukemia

Interventions

• DRUG: Enasidenib Mesylate
• DRUG: Liposome-encapsulated Daunorubicin-Cytarabine

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

• [object Object]